NHAAAD Calls Attention to HIV and Aging, Gladstone Center Aims to Provide Answers

National HIV/AIDS and Aging Awareness Day (September 18) offers an opportunity to recognize the impact of HIV and AIDS among older adults. A growing body of evidence indicates that age-related immune decline and progression to age-associated conditions is more rapid in HIV positive people. The new Center for HIV and Aging at Gladstone is exploring the underlying mechanisms and working to discover interventions that could potentially help both people with HIV and the aging population as a whole.

Read more:

FDA Approves New Fosamprenavir Dose Regimen, Nevirapine Tablets for HIV+ Children

The U.S. Food and Drug Administration (FDA) has approved new dosing recommendations for use of fosamprenavir (Lexiva) oral suspension for children with HIV. The agency also approved a generic nevirapine tablet for use by HIV positive children in PEPFAR countries.

Read more:

NHAAAD, September 18, Features Webinar, SF Forum

Tuesday is National HIV/AIDS and Aging Awareness Day. According to the U.S. Department of Health and Human Services, approximately 30% of Americans living with HIV/AIDS are age 50 or older. A growing body of research is looking at suspected "accelerated aging" among HIV positive people, but much remains unknown. An AIDS Institute webinar and a forum in San Francisco will look at what we know and how we can meet the needs of this population.

Read more:

New Guidelines: Antiretroviral Therapy and Optimized Care for People with HIV

The U.S. Department of Health and Human Services this week released updated Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. DHHS panel member Paul Dalton provides a summary of the changes.

Earlier this month the International Association of Physicians in AIDS Care (IAPAC) released guidelines for improving entry into and retention in care for people with HIV, as well as optimizing adherence to antiretroviral therapy.

Read more: